StonvexLoading…
StonvexStonvexStonvexCore line items from CHWY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-02-01 | Annual 2025 2025-02-02 | Annual 2024 2024-01-28 | Annual 2023 2023-01-29 |
|---|---|---|---|---|
Revenue | $12.60B | $11.86B | $11.15B | $10.12B |
Operating Income | $254.30M | $112.60M | $-23.60M | $56.42M |
Net Income | $222.80M | $392.70M | $39.60M | $49.90M |
EPS (Diluted) | $0.52 | $0.91 | $0.09 | $0.12 |
Total Assets | $3.37B | $3.01B | $3.19B | $2.52B |
Total Liabilities | $2.87B | $2.75B | $2.68B | $2.36B |
Cash & Equivalents | $860.10M | $595.80M | $602.23M | $331.64M |
Free Cash Flow OCF − CapEx | $562.40M | $452.50M | $342.90M | $119.47M |
Shares Outstanding | 425.80M | 431.00M | 432.00M | 427.77M |